<SEC-DOCUMENT>0001785530-22-000037.txt : 20221110
<SEC-HEADER>0001785530-22-000037.hdr.sgml : 20221110
<ACCEPTANCE-DATETIME>20221110070540
ACCESSION NUMBER:		0001785530-22-000037
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221110
DATE AS OF CHANGE:		20221110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Werewolf Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001785530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823523180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40366
		FILM NUMBER:		221374882

	BUSINESS ADDRESS:	
		STREET 1:		200 TALCOTT AVENUE
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-952-0555

	MAIL ADDRESS:	
		STREET 1:		200 TALCOTT AVENUE
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>howl-20221110.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:5fc75829-ccab-4d9d-becf-5381f0976004,g:72457461-7930-448a-99a6-2a10c4eaad45,d:cfaac6e296e5470abc20fa0f01c830e2--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>howl-20221110</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie6f68d54213a496ebb7cdcdf7ed945c9_D20221110-20221110" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNmYWFjNmUyOTZlNTQ3MGFiYzIwZmEwZjAxYzgzMGUyL3NlYzpjZmFhYzZlMjk2ZTU0NzBhYmMyMGZhMGYwMWM4MzBlMl80L2ZyYWc6MjdkMTdjNTIwZWI4NDNmOGIyODg5ODYxOWY5MjI3ZTgvdGFibGU6NTc3MDU1YTIxYzQxNDgzYmJlM2VjMjEzN2RmN2FmMDYvdGFibGVyYW5nZTo1NzcwNTVhMjFjNDE0ODNiYmUzZWMyMTM3ZGY3YWYwNl8wLTEtMS0xLTQ1MDI5_055bb984-d277-41dc-988b-25fb6cea94c5">0001785530</ix:nonNumeric><ix:nonNumeric contextRef="ie6f68d54213a496ebb7cdcdf7ed945c9_D20221110-20221110" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNmYWFjNmUyOTZlNTQ3MGFiYzIwZmEwZjAxYzgzMGUyL3NlYzpjZmFhYzZlMjk2ZTU0NzBhYmMyMGZhMGYwMWM4MzBlMl80L2ZyYWc6MjdkMTdjNTIwZWI4NDNmOGIyODg5ODYxOWY5MjI3ZTgvdGFibGU6NTc3MDU1YTIxYzQxNDgzYmJlM2VjMjEzN2RmN2FmMDYvdGFibGVyYW5nZTo1NzcwNTVhMjFjNDE0ODNiYmUzZWMyMTM3ZGY3YWYwNl8xLTEtMS0xLTQ1MDI5_2a8282b0-